User Reviews for Zorbtive

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Filter by:

Learn more about Zorbtive.

Condition	Reviews	Compare	Avg. Ratings
Short Bowel Syndrome	0 reviews	8 medications	Not rated - Be the first
Short Stature for Age	0 reviews	15 medications	Not rated - Be the first

Reviews for Zorbtive

There are no reviews - Be the first

Related Zorbtive Information

Availability Prescription only

CSA Schedule Not a controlled drug

Pregnancy Category Risk cannot be ruled out

Approval History Drug history at FDA

FDA Consumer Updates

More FDA Updates...

Related Pages

Drug Class

Growth hormones

Recently Approved

Mitosol
Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.
Sklice
Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in ...
Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide ...
Kalydeco
Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated ...
Erivedge
Erivedge (vismodegib) is a hedgehog pathway inhibitor for the treatment of patients with advanced basal cell ...

More...

Get Updates by Email

Email me about Zorbtive:

Related News and Articles

NPS Pharmaceuticals Announces FDA Acceptance of New Drug Application for Gattex (teduglutide) for the Treatment of Adult Short Bowel Syndrome (SBS) 31 January 2012
Jan 31, 2012 - NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine...
NPS Pharmaceuticals Completes Submission of New Drug Application for Gattex (teduglutide) in Adult Short Bowel Syndrome (SBS) 1 December 2011
Dec 1, 2011 - NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine...
Phase 3 Gattex (teduglutide) Data Highlight Potential New Treatment for Adults with Short Bowel Syndrome 31 October 2011
Four abstracts, including new data from STEPS 2, presented at American College of Gastroenterology Annual Scientific Meeting BEDMINSTER, N.J.--Oct. 31,...
NPS Pharmaceuticals Reports Upcoming Presentations at American College of Gastroenterology Annual Scientific Meeting 24 October 2011
Studies support the efficacy of GATTEX (teduglutide) in patients with short bowel syndrome Abstracts can be viewed online BEDMINSTER, N.J.--(BUSINESS...
NPS Pharmaceuticals Submits Chemistry, Manufacturing and Controls (CMC) Section of New Drug Application for Gattex 18 August 2011
Aug 18, 2011 - NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine...

Help and Support

Looking for answers? Ask a question or go join the Zorbtive support group to connect with others who have similar interests.

Did you find this page helpful? Yes No

Support

About Drugs.com

Your Privacy

Follow us on: Google+ Facebook Twitter

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.

Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.

We comply with the HONcode standard for trustworthy health information.
Verify here

Terms of Use · Privacy Policy

Browse all medications A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Advanced Phonetic
Search:

User Reviews for Zorbtive

Reviews for Zorbtive

See also...

Related Zorbtive Information